Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Hypertension

Cardiovascular · Known disease · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 30.6% of adults aged 18 to 74 in 2015 (Esteban study), of whom 47% treated [1]

Initial tests

Fasting sample.

Fasting laboratory tests

Urine tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Annual follow-up tests

Laboratory tests

Urine tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Follow-up tests every 3 years

Fasting sample.

Fasting laboratory tests

Urine tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Tests for resistant hypertension

Laboratory tests

24-hour urine collection

Detailed explanation and international comparison (in French): read it in English (machine translation)

Hypertension before age 40

Fasting sample.

Fasting laboratory tests, in the morning

Urine tests

Depending on the clinical picture

Detailed explanation and international comparison (in French): read it in English (machine translation)

BP ≥ 180/110 mmHg: hypertensive emergency or severe hypertension without organ damage

Detailed explanation and international comparison (in French): read it in English (machine translation)

Hypertension in children and adolescents: initial tests

Laboratory tests

Urine tests (first morning urine)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (15)
  1. L'hypertension artérielle en France : prévalence, traitement et contrôle en 2015 et évolutions depuis 2006
  2. Recommandations de la société européenne d'HTA (2023)
  3. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024;45(38):3912-4018.
  4. Haute Autorité de santé, Société française d’hypertension artérielle. Prise en charge de l’hypertension artérielle de l’adulte. Fiche mémo, septembre 2016.
  5. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1577 (HbA1c).
  6. Baguet JP, Steichen O, Mounier-Véhier C, Gosse P. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA? Ann Endocrinol (Paris) 2016;77(3):187-91.
  7. Cameron NA, Jones DW, Khan SS, Lloyd-Jones DM. Case-Based Applications of the 2025 AHA/ACC/Multispecialty High Blood Pressure Guideline. Hypertension. 2025;82(12):2055-2063 (article des auteurs de la recommandation AHA/ACC 2025, qui en reprend les recommandations et leurs niveaux de preuve).
  8. Consensus SFE/SFHTA/AFCE sur l’hyperaldostéronisme primaire, partie 2 : premières étapes diagnostiques (version française, SFHTA, 2016).
  9. National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management. NICE guideline NG136, publiée le 28 août 2019, mise à jour le 26 février 2026 : recommandations 1.3.3, 1.4.46 à 1.4.52 et revue annuelle.
  10. Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Hypertonie, version longue, version 1.0, 2023 (AWMF-Register-Nr. nvl-009).
  11. Goupil R, Tsuyuki RT, Santesso N, et al. Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care. CMAJ 2025;197(20):E549-E564. doi:10.1503/cmaj.241770
  12. Bouhanick B, Sosner P, Brochard K, Mounier-Véhier C, Plu-Bureau G, Hascoet S, et al. Hypertension in children and adolescents: a position statement from a panel of multidisciplinary experts coordinated by the French Society of Hypertension. Front Pediatr 2021;9:680803.
  13. Collège national des pédiatres universitaires (CNPU). Référentiel de pédiatrie, chapitre 50 : Hypertension artérielle.
  14. Prise en charge de l’hypertension artérielle de l’adulte
  15. Douillard C, Houillier P, Nussberger J, Girerd X. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 2: first diagnostic steps. Ann Endocrinol (Paris) 2016;77(3):192-201.